Patron Exim Peer Comparison

BSE: 543798

₹1.90

₹0.01 (0.53%)

As on 17-Sep-2026IST

Market cap

₹4 Cr

Revenue (TTM)

₹24 Cr

P/E Ratio

--

P/B Ratio

0.1

Div. Yield

0 %

Edit

	Patron Exim	Emcure Pharmaceuticals	Neuland Lab	Alivus Life Sciences	Concord Biotech
Market cap (₹ Cr)	4	38,241	29,349	17,570	15,629
Revenue (₹ Cr)	24	9,683	2,372	2,590	1,108
Net Profit (₹ Cr)	0.07	1,018.97	497.77	603.02	270.18
Net Margin (%)	0.29	10.47	20.72	22.63	23.29
RoE (%)	0.18	21.30	28.49	19.61	14.45
Price to Earnings	--	37.81	58.96	29.14	56.75
Price-To-Book	0.11	7.31	14.52	5.04	7.54

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Patron Exim	Emcure Pharmaceuticals	Neuland Lab	Alivus Life Sciences	Concord Biotech
Operating Revenue	24.36	7,896.00	1,476.84	2,386.88	1,200.09
Total Income	24.68	7,968.78	1,497.35	2,421.45	1,244.53
Total Expenditure	24.57	6,427.14	1,153.58	1,704.30	693.24
EBITDA	-0.21	1,468.85	323.26	682.58	506.84
Depreciation	0.00	384.13	65.55	60.61	54.37
EBIT	-0.21	1,084.73	257.71	621.98	452.47
Interest	--	175.78	8.30	2.41	1.04
Other Income	0.32	72.79	20.51	34.57	44.45
Exceptional Items	--	-10.38	76.40	--	--
Profit before Tax	0.11	971.35	346.33	654.13	494.55
Provision for Tax	0.04	263.88	86.22	168.50	122.91
Profit after Tax	0.07	707.47	260.11	485.63	371.64

Liabilities (₹ Cr)

	Patron Exim	Emcure Pharmaceuticals	Neuland Lab	Alivus Life Sciences	Concord Biotech
Shareholder's Funds	39.21	4,446.19	1,524.81	2,817.37	1,812.72
Minority Interest	--	195.37	--	--	--
Non-Current Liabilities	--	811.91	189.39	466.05	37.47
Current Liabilities	5.04	2,668.27	465.69	470.16	184.06
Total Liabilities	44.25	8,121.73	2,179.88	3,753.59	2,034.25

Assets (₹ Cr)

	Patron Exim	Emcure Pharmaceuticals	Neuland Lab	Alivus Life Sciences	Concord Biotech
Non-Current Assets	0.01	3,565.87	1,040.38	1,418.43	899.01
Current Assets	44.25	4,555.86	1,139.50	2,335.16	1,135.24
Total Assets	44.25	8,121.73	2,179.88	3,753.59	2,034.25
Total Debt*	0.23	731.70	136.01	0.00	0.38
Net Current Assets	39.20	1,887.59	673.81	1,865.00	951.18
Contingent Liabilities	--	393.94	8.97	4.82	3.91

Cashflow (₹ Cr)

	Patron Exim	Emcure Pharmaceuticals	Neuland Lab	Alivus Life Sciences	Concord Biotech
Cash From Operating Activities	-0.01	851.71	317.40	391.52	244.52
Cash Flow from Investing Activities	0.00	-94.00	-298.16	-615.65	-159.99
Cash from Financing Activities	-0.03	-813.96	24.96	-6.23	-98.77
Net Cash Inflow / Outflow	-0.04	-56.25	44.21	-230.35	-14.24

Ratios

Profitability Ratios

	Patron Exim	Emcure Pharmaceuticals	Neuland Lab	Alivus Life Sciences	Concord Biotech
ROCE (%)	0.27	22.49	23.45	25.50	29.62
ROE (%)	0.18	19.19	18.54	18.94	22.26
ROA (%)	0.16	8.94	12.97	13.34	19.90
EBIT Margin (%)	0.45	19.52	23.28	30.05	45.94
Net Margin (%)	0.29	8.88	17.37	20.06	29.86
Cash Profit Margin (%)	0.30	13.61	22.05	22.79	35.50

Growth Ratios

	Patron Exim	Emcure Pharmaceuticals	Neuland Lab	Alivus Life Sciences	Concord Biotech
Revenue Growth (%)	270.47	18.59	-5.24	4.54	18.01
EBIT Growth (%)	-87.94	19.81	-27.65	4.50	18.31
Net Profit Growth (%)	-89.34	34.10	-13.32	3.13	20.62
EPS Growth (%)	-89.35	30.75	-13.32	3.12	20.62
Book Value Growth (%)	0.18	50.94	18.89	20.94	18.74

Valuation Ratios

	Patron Exim	Emcure Pharmaceuticals	Neuland Lab	Alivus Life Sciences	Concord Biotech
Price / Earnings	211.44	29.84	59.57	27.24	47.19
Price / Book Value	0.38	4.58	10.17	4.71	9.67
Dividend Yield (%)	0.00	0.28	0.10	0.46	0.64
EV/EBITDA	137.32	13.55	44.72	18.35	31.81
Market Cap (₹ Cr)	15.00	20,327.45	15,494.53	13,228.83	17,537.35

Solvency Ratios

	Patron Exim	Emcure Pharmaceuticals	Neuland Lab	Alivus Life Sciences	Concord Biotech
Debt to Equity	0.01	0.17	0.09	0.00	0.00
Short term debt to equity ratio	0.01	0.11	--	--	0.00
Current Ratio	8.77	1.71	2.45	4.97	6.17
Quick Ratio	8.30	0.98	1.62	3.53	4.87
Interest Coverage	--	6.53	42.74	271.97	475.76

Operating Efficiency Ratios

	Patron Exim	Emcure Pharmaceuticals	Neuland Lab	Alivus Life Sciences	Concord Biotech
Debtors to sales (%)	25.07	25.36	21.38	40.63	43.47
Asset Turnover	0.54	1.01	0.74	0.66	0.64
Receivable days	121.64	87.83	85.17	132.12	132.49
Inventory Days	35.63	78.64	90.97	102.08	68.07
Payable days	73.02	174.97	137.94	133.54	123.94
Cash Conversion Cycle	84.25	-8.50	38.21	100.66	76.63

Annual
Quarterly